Where can researchers source third-party tested NAD+?

Midwest Peptide supplies research-grade NAD+ with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

NAD+ Longevity Studies: Animal Lifespan | Midwest Peptide

KLOW Peptide Blend: A Comprehensive Research Overview of GHK-Cu, BPC-157, KPV & TB-500Prev|NAD+ Precursors Compared: NR, NMN, and NAD+ in Research ModelsNext

NAD+ and Longevity Research: Animal Model Studies on Lifespan Endpoints

Q: Is NAD+ approved for human use?

No. NAD+ is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

NAD+ · Published April 8, 2026 · Updated May 18, 2026 · 9 min read

Quick Answer

NAD+ longevity research examines lifespan endpoints across yeast, C. elegans, Drosophila, and rodent animal models, including sirtuin connections and NAD+ biosynthesis pathways. Studies measure chronological lifespan, healthspan markers, and age-associated biomarkers across standardized longevity research protocols. For research use only, not for human consumption.

NAD+ and Longevity Research: Animal Model Studies on Lifespan Endpoints

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

The Origin of NAD+ Longevity Research
NAD+ in Yeast and Invertebrate Lifespan Research
Rodent Research Models and Mammalian Lifespan Studies
Methodological Considerations in Animal Lifespan Research
NAD+ Mitochondrial and Sirtuin Connections
NAD+ Longevity Research in the Broader NAD+ Cluster
Open Research Questions
Compliance Note
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

NAD+ longevity studies in animal research models represent one of the most discussed and conceptually rich areas of preclinical investigation in the broader NAD+ literature. Studies in invertebrate and rodent research models have examined whether interventions that raise NAD+ levels can affect lifespan endpoints, mitochondrial function in aged research animals, and other measurable markers of biological aging. As the longevity research component of the NAD+ research cluster, this article reviews the published animal model literature on NAD+ and lifespan endpoints, with strict framing in the context of preclinical research only.

Frequently Asked Questions

What is NAD+ in research contexts?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell, central to redox metabolism and serving as a substrate for sirtuins, PARP enzymes, and CD38. It is studied in research models for cellular energy, mitochondrial function, DNA repair, and aging biology.

What does the NAD+ longevity research literature show?

Lifespan studies in yeast (replicative lifespan), C. elegans, Drosophila, and rodents demonstrate that NAD+ availability and sirtuin activity correlate with lifespan extension. NAD+ precursor supplementation (NR, NMN) extends median lifespan in some rodent studies.

What lifespan endpoints are measured in NAD+ research?

Endpoints include median and maximal lifespan, healthspan markers (frailty, functional capacity), age-associated disease incidence, and integrated assessment of biological age via clocks like DNA methylation patterns or transcriptomic signatures.

Is NAD+ approved for human use?

Glossary

Key terms used in this article.

NAD+/NADH: The oxidized (NAD+) and reduced (NADH) forms of nicotinamide adenine dinucleotide, central to redox metabolism.
Sirtuin: A family of NAD+-dependent deacylase enzymes (SIRT1 to SIRT7) that regulate metabolism, stress response, and aging.
PARP: Poly(ADP-ribose) polymerase, a family of NAD+-consuming enzymes critical for DNA damage repair.
NMN: Nicotinamide mononucleotide, a direct biosynthetic precursor to NAD+ studied as a supplementation strategy.
NR: Nicotinamide riboside, an NAD+ precursor that is converted to NMN by NRK enzymes before incorporation into NAD+.
Median Lifespan: The age at which 50% of a cohort has died, the most common lifespan endpoint in aging research.
Healthspan: The period of life lived in good health, distinct from total lifespan, and a key endpoint in aging research.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. This article discusses preclinical animal model research exclusively. NAD+ is intended only for in vitro and laboratory research, is not approved for human use, is not a drug, supplement, or anti-aging product, and is not associated with any human longevity claims. All findings discussed below are from controlled animal research models and do not translate to human contexts.

The Origin of NAD+ Longevity Research

NAD+ longevity research emerged from observations in the early 2000s that connected sirtuin enzymes to lifespan endpoints in research models. The yeast Sir2 gene, which encodes a sirtuin homolog, was shown to influence replicative lifespan in yeast research models, and this finding sparked broader interest in whether the NAD+ dependence of sirtuins could link cellular metabolism to aging in animal research models. Subsequent work in C. elegans and Drosophila research models extended the link between sirtuin activity and lifespan to invertebrate animals, providing additional foundational data for the field.

A second observation that shaped NAD+ longevity research was the report that NAD+ levels appeared to decline with age in research animals across multiple tissues. This observation, replicated in several published studies, suggested that aged research animals might have reduced sirtuin activity due to declining NAD+ availability, which in turn could contribute to age associated changes in metabolism, mitochondrial function, and other endpoints studied in animal models. The hypothesis that restoring NAD+ levels could reverse age associated phenotypes in research models became one of the central testable questions in the field.

These two observations together established the conceptual framework for NAD+ longevity research in animal models. The framework is straightforward at a high level: NAD+ levels decline with age, sirtuin activity depends on NAD+ availability, sirtuins have been linked to lifespan endpoints in research models, and therefore raising NAD+ levels in aged research animals might affect those endpoints. Whether this framework holds up in detailed preclinical studies has been the subject of substantial investigation over the past two decades.

NAD+ in Yeast and Invertebrate Lifespan Research

The yeast model has been particularly influential in NAD+ longevity research because of its genetic tractability and the ability to measure replicative lifespan directly. Studies in yeast have used genetic manipulations of NAD+ biosynthesis enzymes, sirtuin overexpression and deletion, and pharmacological interventions to characterize how NAD+ pathway components influence yeast lifespan. The general pattern in the published yeast literature is that interventions which preserve or raise NAD+ levels are associated with extended replicative lifespan, while interventions that reduce NAD+ availability are associated with shortened lifespan in this research model.

C. elegans research models have been used to extend these findings to a multicellular animal context. Studies have examined how NAD+ pathway manipulations affect adult lifespan in C. elegans, with published research generally reporting that interventions that raise NAD+ levels can extend lifespan in this model. The connection to sirtuin activity has been studied through genetic manipulations of the C. elegans sir-2.1 gene, which is a homolog of mammalian SIRT1.

Drosophila research models have provided additional evidence on the relationship between NAD+ availability and lifespan in invertebrate animals. As with the yeast and C. elegans literature, the general pattern is that interventions which raise NAD+ levels or enhance sirtuin activity are associated with positive effects on lifespan endpoints in research models, although the specific mechanisms and the magnitudes of the effects vary across studies and experimental conditions.

Rodent Research Models and Mammalian Lifespan Studies

The translation of invertebrate findings to mammalian research models has been one of the more active and complex areas of NAD+ longevity research. Rodent models, particularly mice, have been used to study how NAD+ pathway interventions affect age associated phenotypes and lifespan endpoints in mammals. The published literature in this area is more nuanced than the invertebrate findings, with results that depend significantly on the specific intervention, the age and strain of the research animals, and the endpoints measured.

Studies in rodent models have used precursor supplementation, genetic manipulations of NAD+ biosynthesis enzymes, and pharmacological interventions targeting NAD+ consuming enzymes such as CD38 to examine effects on age associated phenotypes. These phenotypes have included measures of mitochondrial function, oxidative stress markers, glucose metabolism, exercise capacity in research animals, and other endpoints that change with age in rodent research models. The general finding in the published literature is that some interventions that raise NAD+ levels can improve some age associated phenotypes in some research conditions, although the effects on actual lifespan endpoints are less consistent and depend on the specifics of each study.

For more on the comparative pharmacology of the precursors used in these studies, see our companion article on NAD+ vs NMN research and NR precursor comparison studies.

Methodological Considerations in Animal Lifespan Research

Animal lifespan studies are methodologically demanding research projects that require large cohorts, careful control of housing and diet conditions, and standardized endpoints for measuring lifespan. The published literature on NAD+ interventions in animal lifespan research has used a range of study designs, from short term studies that measure age associated phenotypes after weeks of intervention, to long term studies that follow research animals throughout their entire lifespan to measure effects on median and maximum lifespan endpoints.

The methodological standards for these studies have evolved over time. Early reports of lifespan extension in research animals sometimes used small cohort sizes or non standard endpoints, which raised questions about reproducibility. More recent studies have used larger cohorts, multiple research strains, and standardized lifespan measurement protocols, providing more reliable data on the effects of NAD+ interventions in animal models. The Interventions Testing Program, a multi site research program that uses standardized lifespan studies in mice, has examined several NAD+ related interventions and provides a useful methodological reference point for the field.

The interpretation of animal lifespan findings requires careful attention to whether reported effects are on median lifespan, maximum lifespan, or healthspan measures, since these endpoints can move independently. An intervention that improves median lifespan in research animals does not necessarily extend maximum lifespan, and vice versa. Healthspan measures, which assess functional capacity at various ages in research animals, provide additional information about how interventions affect aging beyond simple measures of survival.

NAD+ Mitochondrial and Sirtuin Connections

The longevity research literature on NAD+ overlaps substantially with the mitochondrial and sirtuin research areas covered elsewhere in this cluster. Many of the proposed mechanisms by which NAD+ interventions might affect aging in research animals involve mitochondrial function, sirtuin activity, or the intersection of the two. For example, the activation of SIRT1 by raised NAD+ levels could increase PGC-1 alpha activity and promote mitochondrial biogenesis, which has been studied in research models for its effects on age associated declines in mitochondrial function.

For more on the sirtuin pathway specifically, see our companion article on NAD+ sirtuin studies and the SIRT1 to SIRT7 pathway.

The mitochondrial sirtuin SIRT3 has also been studied in this context, since mitochondrial NAD+ levels are particularly relevant for organelle function and since SIRT3 deacetylates a wide range of mitochondrial proteins involved in oxidative phosphorylation and antioxidant defense. The intersection of these pathways with longevity endpoints in research animals is one of the more conceptually rich areas of current investigation.

NAD+ Longevity Research in the Broader NAD+ Cluster

NAD+ longevity research is one of the four major areas covered in the NAD+ research cluster anchored by the NAD+ peptide research pillar. It overlaps with mitochondrial research, sirtuin research, and precursor research, with each of these areas contributing mechanistic and methodological context to the longevity literature.

For research handling, NAD+ supplied for longevity studies should be stored cold and protected from light, with reconstituted solutions prepared shortly before use. The Certificate of Analysis supplied with NAD+ 500mg provides identity and purity information that supports research grade handling decisions.

Open Research Questions

Several open research questions remain in NAD+ longevity research. These include whether interventions that raise NAD+ levels in aged research animals produce consistent effects on maximum lifespan across multiple research strains and study sites, how the reported age associated decline in NAD+ levels varies across tissues and how this affects the interpretation of intervention studies, and whether combinations of NAD+ interventions with other longevity related interventions in research animals produce different results than single interventions. Each of these is a legitimate research opportunity for investigators studying aging in animal models.

Compliance Note

This article discusses preclinical animal model research exclusively. The findings reviewed above are from controlled studies in research animals and do not constitute claims about human longevity, human aging, or human health. NAD+ supplied by Midwest Peptide is for in vitro and preclinical research only and is not intended for any human application. Investigators interested in the published literature on NAD+ and aging should consult the peer reviewed research directly when planning research projects.

Conclusion

NAD+ longevity studies in animal research models represent one of the most discussed areas of preclinical NAD+ research, with a growing body of literature on lifespan endpoints in yeast, C. elegans, Drosophila, and rodent models. The conceptual framework linking NAD+ availability to sirtuin activity to age associated phenotypes provides a foundation for ongoing investigation, and the open questions in the field continue to drive comparative research in standardized animal models. For investigators working in this area, the published literature provides a strong starting point, with the important caveat that all findings are from preclinical research and do not translate to human contexts.

For more on the full NAD+ research cluster, see the pillar overview article and the supporting articles on each major research area.

NAD+ is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

NAD+ 500mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included
BPC-157 10mg, 99%+ purity, COA included
Bacteriostatic Water, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

NAD+ and Longevity Research: Animal Model Studies on Lifespan Endpoints

Frequently Asked Questions

What is NAD+ in research contexts?

What does the NAD+ longevity research literature show?

What lifespan endpoints are measured in NAD+ research?

Is NAD+ approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

The Origin of NAD+ Longevity Research

NAD+ in Yeast and Invertebrate Lifespan Research

Rodent Research Models and Mammalian Lifespan Studies

Methodological Considerations in Animal Lifespan Research

NAD+ Mitochondrial and Sirtuin Connections

NAD+ Longevity Research in the Broader NAD+ Cluster

Open Research Questions

Compliance Note

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested NAD+?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

NAD+ and Longevity Research: Animal Model Studies on Lifespan Endpoints

Frequently Asked Questions

What is NAD+ in research contexts?

What does the NAD+ longevity research literature show?

What lifespan endpoints are measured in NAD+ research?

Is NAD+ approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

The Origin of NAD+ Longevity Research

NAD+ in Yeast and Invertebrate Lifespan Research

Rodent Research Models and Mammalian Lifespan Studies

Methodological Considerations in Animal Lifespan Research

NAD+ Mitochondrial and Sirtuin Connections

NAD+ Longevity Research in the Broader NAD+ Cluster

Open Research Questions

Compliance Note

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested NAD+?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?